NDAORALTABLET
Approved
Aug 2017
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Allopurinol acts on purine catabolism, without disrupting the biosynthesis of purines. It reduces the production of uric acid by inhibiting the biochemical reactions immediately preceding its formation. Allopurinol is a structural analogue of the natural purine base, hypoxanthine. It is an…
Loss of Exclusivity
LOE Date
Feb 29, 2032
72 months away
Patent Expiry
Feb 29, 2032
External Resources